William Blair, BB&T Downgrades Pharmaceutical Product Development (PPDI)
Tweet
Share
E-mailGet Alerts PPDI Hot Sheet
Price: $33.24 --0%
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
1 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
William Blair downgraded shares of Pharmaceutical Product Development (NASDAQ: PPDI) from Outperform to Market Perform Monday following news of a $3.9 billion offer for the company.
Elsewhere, BB&T Capital downgraded the stock from Buy to Hold.
Shares of PPD are up more than 25 percent to over $32 Monday.
For more ratings news on Pharmaceutical Product Development click here and for the rating history of Pharmaceutical Product Development click here.
Elsewhere, BB&T Capital downgraded the stock from Buy to Hold.
Shares of PPD are up more than 25 percent to over $32 Monday.
For more ratings news on Pharmaceutical Product Development click here and for the rating history of Pharmaceutical Product Development click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades Enovix Corporation (ENVX) to Market Perform
- Clear Street Downgrades Kinetik Holdings, Inc. (KNTK) to Hold Citing Valuation
- Macquarie Downgrades Northern Star Resources (NST:AU) (NESRF) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
William Blair, BB&T Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
